| No. | Internal ID | Principal Investigator | Protocol ID | Phase | Sponsor |
|---|---|---|---|---|---|
| 65. | GYFKK/47/2016 | Prof. Dr. Szilasi Mária | PM 0259 CA 232 J1 | III. | F.Hoffmann- La Roche Ltd. |
| 66. | GYFKK/19/2016 | Prof. Dr. Csanádi Zoltán | GE-122-020 | III. | GE Healtheare Ltd. |
| 67. | GYFKK/77/2016 | Prof. Dr. Kovács Péter | 768B15 | I. | PRS KFT. |
| 68. | GYFKK/37/2016 | Prof. Dr. Remenyik Éva | P15-769 | BNJ. | AbbVie Kft. |
| 69. | GYFKK/65/2016 | Prof. Dr. Kovács Péter | 114B16 | I. | PRS KFT. |
| 70. | GYFKK/59/2016 | Dr. Balogh Zoltán | GLARGL07657 | BNJ. | Sanofi- Aventis Zrt |
| 71. | GYFKK/53/2016 | Prof. Dr. Remenyik Éva | CNTO1275PS03013 | III. | Janssen- Cilag Kft |
| 72. | GYFKK/54/2016 | Dr. Kocsis Judit | EMR1000070-007 | III. | Quintiles Mo. Kft. |
| 73. | GYFKK/8/2016 | Prof. Dr. Póka Róbert | B9991009 | III | Pfizer |
| 74. | GYFKK/13/2016 | Prof. Dr. Csanádi Zoltán | BIOGUARD MI | BNJ. | BIOTRONIC SE&CO KG. |
| 75. | GYFKK/55/2016 | Dr. Kocsis Judit | IMP321-P011 | II. | Immuntep S. A. |
| 76. | GYFKK/219/2015 | Prof. Dr. Csanádi Zoltán | GOLD AF | Reg. | Medtronic Hungária Kft. |
| 77. | GYFKK/74/2016 | Prof. Dr. Kappelmayer János | CLBH589D2222 | II. | Novartis Hungária Kft. |
| 78. | GYFKK/45/2016 | Dr. Kocsis Judit | HALO-109-301 | III. | Halozyme, Inc |
| 79. | GYFKK/32/2016 | Prof. Dr. Boda Zoltán | 261303 | III. | Baxalta Innovations GmbH |
| 80. | GYFKK/31/2016 | Dr. Csépány Tünde | TERIFL07890 | BNJ. | Sanofi-Aventis Zrt |
| 81. | GYFKK/90/2016 | Prof. Dr. Dankó Katalin | 8400-211 | II. | Ideara Pharmaceuticals Inc. |
| 82. | GYFKK/48/2016 | Prof. Dr. Szilasi Mária | GO30081 | III. | F. Hoffmann- La Roche Ltd. |
| 83. | GYFKK/79/2016 | Prof. Dr. Illés Árpád | AC220-A-U302 | III. | Covance Hungária Kft. |
| 84. | GYFKK/84/2016 | Dr. Vajas Attila | TG-MV-015 | II. | ThromboGenics |
| 85. | GYFKK/72/2016 | Dr. Kocsis Judit | 1VIT14039 | III. | KCR S.A. |
| 86. | GYFKK/80/2016 | Dr. Szántó Sándor | MS200527-0081 | II/A. | Merck KGaA |
| 87. | GYFKK/83/2016 | Dr. Vajas Attila | BAY 86-5321/17613 | IV. | Bayer HealthCare AG |
| 88. | GYFKK/118/2016 | Prof. Dr. Páll Dénes | AKB-6548-CI-0014, AKB-6548-CI-0015 | III. | Quintiles Mo. Kft. |
| 89. | GYFKK/89/2016 | Dr. Horváth Zsolt | MK-3475-355 | III. | MSD Hungary Kft. |
| 90. | GYFKK/88/2016 | Dr. Horváth Zsolt | MK-3475-426 | III. | MSD Hungary Kft. |
| 91. | GYFKK/82/2016 | Prof. Dr. Kiss Csongor | 54179060LYM303 | III. | Janssen-Cilag Kft |
| 92. | GYFKK/63/2016 | Prof. Dr. Édes István | APD811-007 | II. | Arena Pharmaceuticals |
| 93. | GYFKK/64/2016 | Prof. Dr. Édes István | APD811-003 | II. | Arena Pharmaceuticals |
| 94. | GYFKK/81/2016 | Prof. Dr. Csanádi Zoltán | BUC-CLIN-303 | II-III. | ARCA Biopharma Inc. |
| 95. | GYFKK/102/2016 | Prof. Dr. Balla György | 03-CL-1202 | II/B. | Windtree Therapautics Inc. |
| 96. | GYFKK/66/2016 | Prof. Dr. Zeher Margit | D3461C00009 | III. | Pharmaceutical Research |
| 97. | GYFKK/93/2016 | Dr. Csépány Tünde | 109MS421 | BNJ. | Quintiles Mo. Kft. |
| 98. | GYFKK/97/2016 | Prof. Dr. Szilasi Mária | M14-361 | II. | AbbVie Inc. |
| 99. | GYFKK/120/2016 | Prof. Dr. Kovács Péter | 725B15 | I. | PRS KFT. |
| 100. | GYFKK/91/2016 | Prof. Dr. Altorjay István | LYC-30937-2001 | II. | ICON Klinikai Kutató Kft. |
| 101. | GYFKK/112/2016 | Dr. Horváth Zsolt | CPDR001X2101 | I. | Novartis Hungária Kft. |
| 102. | GYFKK/99/2016 | Dr. Csépány Tünde | OBS14449 | BNJ. | Sanofi-Aventis Zrt |
| 103. | GYFKK/94/2016 | Prof. Dr. Szilasi Mária | MYL-1402O-3001 | III. | Mylan GmbH |
| 104. | GYFKK/62/2016 | Dr. Csutak Adrienne | LT1580-301 | III. | Laboratoires Théa |
| 105. | GYFKK/111/2016 | Prof. Dr. Póka Róbert | B9991010 | III. | Pfizer |
| 106. | GYFKK/86/2016 | Prof. Dr. Remenyik Éva | PM1541 | III. | Covance Hungaria Kft. |
| 107. | GYFKK/130/2016 | Prof. Dr. Kovács Péter | 674B15 | I. | PRS KFT. |
| 108. | GYFKK/128/2016 | Prof. Dr. Boda Zoltán | ALX0681-C302 | III. | Ablynx NV |
| 109. | GYFKK/92/2016 | Prof. Dr. Szilasi Mária | CCD-06001AA1-01 | II/B. | Chiesi Famaceutici S. p. A. |
| 110. | GYFKK/115/2016 | Dr. Kocsis Judit | GLIOMARK1 | II. | CPS Cortex Kft. |
| 111. | GYFKK/108/2016 | Prof. Dr. Remenyik Éva | LRP/LNP/1955/2016/003 | II. | Quintiles Mo. Kft. |
| 112. | GYFKK/78/2016 | Prof. Dr. Illés Árpád | SGN33A-005 | III. | Seattle Genetics Inc. |
| 113. | GYFKK/110/2016 | Dr. Horváth Zsolt | BO25430 | III. | Quintiles Mo. Kft. |
| 114. | GYFKK-114/2016 | Prof. Dr. Illés Árpád | M14-031 | III. | AbbVie |
| 115. | GYFKK/113/2016 | Prof. Dr. Zeher Margit | CDZ173X2203 | II. | Novartis Pharma AG |
| 116. | GYFKK/87/2016 | Dr. Tornai István | 747-303 | III. | Intercept Pharmac. Inc. |
| 117. | GYFKK/121/2016 | Prof. Dr. Altorjay István | GED0507-UC-001 | II. | Quintiles Mo. Kft. |
| 118. | GYFKK/103/2016 | Prof. Dr. Altorjay István | MLN0002-3026 | III/B. | Takeda Ltd. |
| 119. | GYFKK/104/2016 | Dr. Vajas Attila | GX30191 | III/B. | Quintiles Mo. Kft. |
| 120. | GYFKK/133/2016 | Prof. Dr. Paragh György | MK8825004/B1521021 | III. | Parexel Magyarország Kft. |
| 121. | GYFKK/106/2016 | Prof. Dr. Édes István | COOL-AMI EU PILOT | I | ZOLL Circulation |
| 122. | GYFKK/105/2016 | Prof. Dr. Remenyik Éva | BILA-3716/PRU | IV. | Linical Europe GmbH |
| 123. | GYFKK/85/2016 | Dr. Szűcs Gabriella | MC-TER.2/SSc | III. | PPD Magyarország Kft |
| 124. | GYFKK/116/2016 | Prof. Dr. Boda Zoltán | 992 | III. | BIOTEST |
| 125. | GYFKK/68/2016 | Prof. Dr. Remenyik Éva | PS0010 | II/B. | UCB/Parexel International |
| 126. | GYFKK/117/2016 | Dr. Vajas Attila | BAY86-5321/17508 | IV. | Bayer HealthCare AG |
| 127. | GYFKK/107/2016 | Prof. Dr. Póka Róbert | CO-338-043 | III. | Clovis Oncology Inc. |
| 128. | GYKK/126/2016 | Dr. Kocsis Judit | ARRAY-818-302 | III. | Parexel Magyarország Kft. |
| 129. | GYFKK/129/2016 | Prof. Dr. Illés Árpád | CINC424A2X01B | IV. | Novartis Hungária Kft. |
| 130. | GYFKK/122/2016 | Prof. Dr. Kiss Csongor | CICL670F2202 | II. | Novartis Hungária Kft. |
| 131. | GYFKK/134/2016 | Prof. Dr. Illés Árpád | CA209-647 | II. | Bristol-Myers Squibb Kft. |
Last update:
2023. 02. 16. 12:55